PRESS

The Wall Street Journal Recognizes Zargis Medical With Technology Innovation Award


Princeton, NJ (September 11, 2006) -- Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE: SI) and a majority-owned subsidiary of Speedus Corp. (NASDAQ: SPDE), today announced that it was selected as a runner-up in The Wall Street Journal's 2006 Technology Innovation Awards. The competition honors breakthrough technologies from around the world in several categories.

 

As published in today's Wall Street Journal, Zargis was selected as a runner-up in the Medical Devices category for Cardioscan, the world's first computer-aided stethoscope that aids physicians in identifying and evaluating murmurs and other heart sounds that may be indicative of cardiovascular disease. In selecting award winners, The Wall Street Journal's panel of judges considered whether the submitted innovations represented breakthroughs from conventional methods, rather than just incremental improvements.

 

"We are thrilled to have received this recognition from The Wall Street Journal," stated Zargis CEO John Kallassy. "Despite the fact that the stethoscope has long served as a representative symbol of medicine, it has remained virtually unchanged for almost two hundred years. By leveraging our state-of-the-art technology to enhance and extend the clinical usefulness of the stethoscope in ways never before imagined, Zargis Medical has brought the age-old practice of assessing heart sounds into the 21st century."

 

About Zargis Medical Corp.

Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE: SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.

 

About Cardioscan

Zargis has developed Cardioscan, the first and only FDA-authorized computer-assisted medical device designed to support physicians in analyzing heart sounds for the identification of suspected systolic and diastolic murmurs. Cardioscan is a non-invasive device that is easy to use, portable, and takes just minutes to perform. The device implements voice-guided protocol and a graphical user interface while maintaining an efficient physician workflow. Cardioscan provides a summary of findings in terms that are readily understood by physicians and offers an additional range of quantitative auscultatory information that cannot be obtained through listening alone.

 

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or phodge@zargis.com, or visit the following Web sites: www.zargis.com and www.speedus.com.



# # #


Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.


 

September 10, 2010
Zargis Signs Agreement to Provide Ontario Telemedicine Network With Remote Stethoscope Solution

July 30, 2010
Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems

July 21, 2010
Zargis Awarded U.S. Army Contract

June 11, 2010
Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc. Exclusive License Agreement Allows Zargis to Expand into Respiratory Sounds Market

June 10, 2010
Zargis Medical Receives Top Honors at Medical Design Excellence Awards

May 27, 2010
Zargis Launches Telemedicine System with Real-Time Transmission of Stethoscope Sounds

May 13, 2010
U.S. Army to Showcase Zargis' Technology at Telemedicine Conference

April 20, 2010
3M Littmann Model 3200/Zargis Cardioscan Honored for Stethoscope/Software Design Innovation

April 12, 2010
Zargis Cardioscan Wins 'Best of the Best' red dot design award

September 29, 2009
Zargis Awarded Follow-On U.S. Army Contract; Mandates Expansion of Two Previous Awards

February 23, 2010
Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia

February 15, 2010
Edison Best New Product Awards Taps 3M and Zargis

January 8th, 2010
Zargis Cardioscan Cleared for Sale in Canada

December 14, 2009
Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com

December 1, 2009 - IN THE NEWS
Popular Science Cardioscan Video

December 1, 2009 - IN THE NEWS
Scoping Out Stethoscopes (Contemporary Pediatrics Magazine)

November 24, 2009
Zargis Cardioscan(TM) Featured on The Early Show on CBS


November 18, 2009 - IN THE NEWS
Zargis Builds a Better Stethoscope

November 12, 2009
3M Health Care and Zargis Medical Awarded "Innovation of the Year" for Littmann(R) Model 3200 Stethoscope with Cardioscan Software

October 21, 2009
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned

September 24, 2009
3M Global Business Manager Ingrid Blair Joins Zargis Board


September 25, 2009 - IN THE NEWS
TAMC Heart Device Approved, Deploys to Pacific Areas

September 17, 2009
Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army

August 25, 2009
Zargis Cardioscan Unveiled Through Global Marketing and Distribution Alliance With 3M Company

August 19, 2009
3M Introduces First Electronic Stethoscope with Bluetooth Wireless Capability

October 9, 2008
Zargis Receives Additional Contracts from U.S. Army

February 20, 2008
Physicians use Cardioscan to Evaluate Student Athletes during Sports Physicals

October 25, 2007
3M and Zargis Announce Global Marketing Alliance

April 18, 2007
Zargis' Cardioscan Receives Televised News Coverage

November 6, 2006
Zargis Awarded U.S. Army Contract

October 9, 2006
Study Shows Cardioscan Leads to 41% Reduction of Unnecessary and Costly Cardiac Referrals by Physicians

September 13, 2006
Study Results for Zargis Cardioscan to be Presented at American Academy of Pediatrics Conference

September 11, 2006
The Wall Street Journal Recognizes Zargis Medical With Technology Innovation Award

November 16, 2005
Panel Agrees Zargis Prototype Would Improve Referral Accuracy with Heart Murmurs

October 26, 2005
Zargis Medical Awarded Fundamental New Patent

June 30, 2005
Zargis Conducts Physician Study to Show Potential Benefits to Physicians, Insurance Companies and Patients

March 15, 2005
Zargis CTO to Speak at Medical Devices Conference

November 29, 2004
White Paper "Computer Aided Auscultation of the Heart, the Clinical Opportunity" Available at Zargis Website

November 12, 2004
Zargis Signs Exclusive Pact With Johns Hopkins University

November 5, 2004
Zargis Medical Announces the Results of a Clinical Study in Hypertrophic Cardiomyopathy (HCM)

September 14, 2004
Zargis Medical receives FDA clearance: Energy Display and Timing Annotation Added to Cardioscan

June 1, 2004
FDA Clears Zargis' Pioneering Medical Device: First Computer-Aided Device to Assist in the Detection of Heart Murmurs

April 6, 2004
Zargis Medical Updates on FDA Submission

January 12, 2004
Healthcare Veteran Joins Zargis Board

October 27, 2003
Siemens Medical Solutions Leader Joins Zargis Board

July 9, 2003
Zargis Awarded Core Patent for Acoustic Cardioscan

May 21, 2003
Zargis Medical Files with FDA for Approval of Zargis Acoustic Cardioscan System

July 15, 2002
Zargis Medical Tests New Technology, Developed at Siemens, to Improve Diagnosis of Heart Murmurs

February 20, 2002
Zargis Medical Appoints Siemens' Veteran Hejazi As President And Chief Executive Officer

March 26, 2001
Siemens' and SPEEDUS' Start-Up, Zargis Medical Corp., Announces Four Appointments to Medical Experts Board; Changes Name From Sound Diagnostics

January 16, 2001
Siemens and SPEEDUS Team Together in Start-Up to Develop Technology For Rapidly Detecting Valvular Heart Disease During Routine Patient Examinations